A New Hope for Spinal Damage Sufferers

Millions of people around the world suffer from back pain due to progressive deterioration of the spinal discs. Despite the widespread burden it places on patients and healthcare systems, no medications can currently halt or reverse its progression. Surgery remains the only available long-term treatment. However, researchers from the Universities of Edinburgh and Bristol have made a groundbreaking discovery that could change this.

By studying zebrafish bred without a functioning copy of the gene associated with collagen IX, a protein that helps bind together the structural fibers inside spinal discs, the researchers discovered several biological processes that could become targets for future back pain treatments. The study revealed that defects in this gene might cause disc disease by altering the structural integrity of the spinal discs.

As the zebrafish grew older, they developed spinal abnormalities that closely resembled disc disease in humans. Their vertebrae fused, while mineral deposits caused the tissue between the bones to become abnormally hard. The researchers then examined patterns of gene activity in the fish to determine which genes had become more or less active. Their analysis revealed problems with fat processing and with mTOR, a pathway that regulates growth, as well as changes involving phosphate control and vitamin A signaling.

Each of these processes has been associated with abnormal mineral accumulation. To investigate how these processes contribute to spinal damage, the researchers tested several approaches that reduced the spinal damage. A bisphosphonate, a type of bone-protecting medication already used to treat osteoporosis, prevented minerals from accumulating. Spinal fusion was also reduced when the fish received less food or were treated with drugs that suppressed fat metabolism.

The results of the study highlight phosphate regulation and fat metabolism as especially promising areas for the development of future medicines. According to Dr. Erika Kague, lead researcher on the study, the discovery of these biological processes provides a new understanding of how spinal damage occurs and offers potential new avenues for treatment.

Back pain affects millions of people worldwide, and current treatments are often limited to surgery. This breakthrough study offers new hope for those suffering from spinal damage. By understanding the biological processes that contribute to spinal damage, researchers can develop more effective treatments to alleviate this debilitating condition.

Dr. Caroline Aylott, Head of Research Delivery at Arthritis UK, commented on the significance of the study: ‘For the 9.5 million people across the UK living with back pain, this research brings fresh hope that potential new therapeutic approaches are on the horizon. We are proud to fund research that is unlocking the science behind the processes leading to spinal disc degeneration.’

Dr. Jef Grainger, Executive Director of Bioscience Advancing Knowledge at BBSRC, added: ‘This research shows how publicly funded discovery bioscience can generate the knowledge needed to address major health challenges. By revealing new knowledge of how healthy biological processes break down in aging-related spinal disc degeneration, the study opens up promising avenues for future treatment development.’